Cargando…

Telomerase activity in melanoma and non-melanoma skin cancer

Telomeres are specialized structures consisting of repeat arrays of TTAGGG(n) located at the ends of chromosomes. They are essential for chromosome stability and, in the majority of normal somatic cells, telomeres shorten with each cell division. Most immortalized cell lines and tumours reactivate t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Parris, C N, Jezzard, S, Silver, A, MacKie, R, McGregor, J M, Newbold, R F
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1999
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362177/ https://www.ncbi.nlm.nih.gov/pubmed/10408692 http://dx.doi.org/10.1038/sj.bjc.6690010

Ejemplares similares

The role of human melanoma cell ICAM-1 expression on lymphokine activated killer cell-mediated lysis, and the effect of retinoic acid
por: Alexander, C L, et al.
Publicado: (1999)

Human Malignant Melanoma
por: MacKie, R. M.
Publicado: (1979)

Non-melanoma skin cancers and glucocorticoid therapy
por: Karagas, M R, et al.
Publicado: (2001)

Cutaneous malignant melanoma in Scotland.
por: MacKie, R. M., et al.
Publicado: (1982)

Comparison between lentigo maligna melanoma and other histogenetic types of malignant melanoma of the head and neck. Scottish Melanoma Group.
por: Cox, N. H., et al.
Publicado: (1996)

Cerebral metastases of cutaneous melanoma.
por: Gupta, G., et al.
Publicado: (1997)

Epidemiology of invasive cutaneous melanoma
por: MacKie, R. M., et al.
Publicado: (2009)

Severe sunburn and subsequent risk of primary cutaneous malignant melanoma in scotland.
por: MacKie, R. M., et al.
Publicado: (1982)

Prognostic models for subgroups of melanoma patients from the Scottish Melanoma Group database 1979-86, and their subsequent validation.
por: MacKie, R. M., et al.
Publicado: (1995)

Hormone replacement therapy after surgery for stage 1 or 2 cutaneous melanoma
por: MacKie, R M, et al.
Publicado: (2004)

Melanoma incidence and mortality in Scotland 1979–2003
por: MacKie, R M, et al.
Publicado: (2007)

TERT Promoter Mutations and Telomerase in Melanoma
por: Guo, Yuchen, et al.
Publicado: (2022)

Cutaneous melanoma
por: Négrier, S, et al.
Publicado: (2001)

The pharmacokinetic advantages of isolated limb perfusion with melphalan for malignant melanoma.
por: Scott, R. N., et al.
Publicado: (1992)

Adjuvant interferon alpha 2b in high risk melanoma – the Scottish study
por: Cameron, D A, et al.
Publicado: (2001)

Utility of adjuvant systemic therapy in melanoma
por: Eggermont, A. M. M., et al.
Publicado: (2009)

Expression of Telomerase Reverse Transcriptase in Psoriatic Lesional Skin
por: Mahmoud, Moushira A., et al.
Publicado: (2006)

Dermoscopy of Melanoma and Non-melanoma Skin Cancers
por: Kato, Junji, et al.
Publicado: (2019)

Detection of circulating carcinoma cells by telomerase activity
por: Gauthier, L R, et al.
Publicado: (2001)

Overexpression of melanoma inhibitory activity (MIA) enhances extravasation and metastasis of A-mel 3 melanoma cells in vivo
por: Guba, M, et al.
Publicado: (2000)

Absence of telomerase activity and telomerase catalytic subunit mRNA in melanocyte cultures
por: Dhaene, K, et al.
Publicado: (2000)

A comparative study of the relative sensitivity and specificity of radiolabelled monoclonal antibody and computerised tomography in the detection of sites of disease in human malignant melanoma.
por: Elliott, A. T., et al.
Publicado: (1989)

Systemic Photoprotection in Melanoma and Non-Melanoma Skin Cancer
por: Hyeraci, Mariafrancesca, et al.
Publicado: (2023)

Matrix metalloproteinases in human melanoma cell lines and xenografts: increased expression of activated matrix metalloproteinase-2 (MMP-2) correlates with melanoma progression
por: Hofmann, U B, et al.
Publicado: (1999)

Telomere length and telomerase activity in malignant lymphomas at diagnosis and relapse
por: Remes, K, et al.
Publicado: (2000)

Telomerase activity in plasma cell dyscrasias
por: Xu, D, et al.
Publicado: (2001)

Prevalence and correlates of skin self-examination practices among cutaneous malignant melanoma survivors
por: Manne, Sharon L., et al.
Publicado: (2020)

Extra c-myc oncogene copies in high risk cutaneous malignant melanoma and melanoma metastases
por: Kraehn, G M, et al.
Publicado: (2001)

Thrombospondin modulates melanoma--platelet interactions and melanoma tumour cell growth in vivo.
por: Boukerche, H., et al.
Publicado: (1995)

Telomerase reverse transcriptase and telomeric-repeat binding factor protein 1 as regulators of telomerase activity in pancreatic cancer cells
por: Yajima, T, et al.
Publicado: (2001)

Investigation of female survival benefit in metastatic melanoma
por: Richardson, B, et al.
Publicado: (1999)

Expression of telomerase-associated protein 1 and telomerase reverse transcriptase in hepatocellular carcinoma
por: Toshikuni, N, et al.
Publicado: (2000)

Eliminating Preoperative Lymphoscintigraphy in Extremity Melanomas
por: McGregor, Andrew, et al.
Publicado: (2018)

Telomerase activity and p53-dependent apoptosis in ovarian cancer cells
por: Akeshima, R, et al.
Publicado: (2001)

Therapeutic cancer vaccination against telomerase: clinical developments in melanoma
por: Ellingsen, Espen Basmo, et al.
Publicado: (2023)

Clinicopathological Evaluation of Non-melanoma Skin Cancer
por: Denadai, Rafael, et al.
Publicado: (2012)

The Air Liquid-interface, a Skin Microenvironment, Promotes Growth of Melanoma Cells, but not Their Apoptosis and Invasion, through Activation of Mitogen-activated Protein Kinase
por: Hong Yee, Chong, et al.
Publicado: (2010)

Malignant melanoma is genetically distinct from clear cell sarcoma of tendons and aponeurosis (malignant melanoma of soft parts)
por: Langezaal, S M, et al.
Publicado: (2001)

Silibinin and non-melanoma skin cancers
por: Prasad, Ram Raj, et al.
Publicado: (2020)

Immunotherapy for Non-melanoma Skin Cancer
por: Shalhout, Sophia Z., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_oim59aq1q8ic8pigjaitlvkt4i